Summary
- Current Price
- As of today, PBE price is $81.77, up +1.60% on
- Current Price vs All-Time High
- PBE price is currently -4.62% below its historical high of $85.73 set on
- Dividend Yield
- PBE current TTM dividend yield is 0.90%
- Next Ex-Dividend
- As of today, the next dividend for PBE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Name | Invesco Biotechnology & Genome ETF |
| Assets Under Management | $247M |
| Expense Ratio | 0.58% |
| Asset Class | Equity |
| Domicile | US |
| Inception Date | |
| Net Asset Value | 78K USD |
| Website | invesco.com |
| Last Ex-Dividend Date | |
| Next Ex-Dividend Date | N/A |
Top 30 Holdings
| Name | Ticker | Weight |
|---|---|---|
| ILMN | 5.48% | |
| UTHR | 5.38% | |
| REGN | 5.20% | |
| GILD | 5.16% | |
| ALNY | 5.06% | |
| BIIB | 5.06% | |
| INCY | 5.06% | |
| AMGN | 5.04% | |
| BCRX | 3.20% | |
| PTGX | 3.00% | |
| RPRX | 2.88% | |
| CPRX | 2.88% | |
| ARWR | 2.86% | |
| NBIX | 2.84% | |
| CDNA | 2.79% | |
| TECH | 2.78% | |
| VCYT | 2.78% | |
| BMRN | 2.77% | |
| HALO | 2.74% | |
| QIA.DE | 2.74% | |
| TGTX | 2.73% | |
| RGEN | 2.66% | |
| PTCT | 2.63% | |
| EXEL | 2.62% | |
| ACAD | 2.61% | |
| VCEL | 2.55% | |
| IONS | 2.52% | |
| COLL | 2.36% | |
| TBPH | 2.04% | |
| MNKD | 1.46% |
Chart
Technicals
| Metric | Date | Value |
|---|---|---|
| $81.77 | ||
| $77.27 | ||
| SMA 200 vs Price | -5.50% | |
| $79.61 | ||
| SMA 50 vs Price | -2.64% | |
| 0.79 | ||
| $1.05 | ||
| 54.39 | ||
| 14.94% | ||
| 18.69% |
Dividends
| Metric | Date | Value |
|---|---|---|
| $0.08 | ||
| N/A | N/A | |
| 0.90% | ||
| $0.74 |
Country Weights
| Country | Weight |
|---|---|
| United States | 97.00% |
| Netherlands | 2.89% |
Sector Weights
| Sector | Weight |
|---|---|
| Healthcare | 97.14% |
FAQ
Does PBE pay dividends?
Yes, the Invesco Biotechnology & Genome ETF does pays dividends, with the most recent payment being $0.08 per share. The last ex-dividend date was on March 22, 2026, and the next ex-dividend date has not been announced yet
What stocks are in PBE?
As of today, Invesco Biotechnology & Genome ETF includes 32 holdings, with 29 of them being companies from 2 different countries and 1 sectors. The most weighted holdings are Illumina, Inc. (5.48%), United Therapeutics Corporation (5.38%) and Regeneron Pharmaceuticals, Inc. (5.2%)
What is the current assets under management for PBE?
Assets under management of Invesco Biotechnology & Genome ETF is $247M
What is PBE average volume?
Average volume of Invesco Biotechnology & Genome ETF is $8,291
What is PBE expense ratio?
Expense ratio of Invesco Biotechnology & Genome ETF is 0.58%
What is PBE inception date?
Inception date of Invesco Biotechnology & Genome ETF is June 23, 2005
Data Sources & References
- PBE Official Website www.invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html
- PBE Profile on Yahoo Finance finance.yahoo.com/quote/PBE